1. Home
  2. PVLA vs OTLY Comparison

PVLA vs OTLY Comparison

Compare PVLA & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • OTLY
  • Stock Information
  • Founded
  • PVLA 2015
  • OTLY 1994
  • Country
  • PVLA United States
  • OTLY Sweden
  • Employees
  • PVLA N/A
  • OTLY N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • OTLY Packaged Foods
  • Sector
  • PVLA Health Care
  • OTLY Consumer Staples
  • Exchange
  • PVLA Nasdaq
  • OTLY Nasdaq
  • Market Cap
  • PVLA 285.2M
  • OTLY 303.5M
  • IPO Year
  • PVLA N/A
  • OTLY 2021
  • Fundamental
  • Price
  • PVLA $36.55
  • OTLY $15.07
  • Analyst Decision
  • PVLA Strong Buy
  • OTLY Buy
  • Analyst Count
  • PVLA 8
  • OTLY 5
  • Target Price
  • PVLA $47.50
  • OTLY $19.60
  • AVG Volume (30 Days)
  • PVLA 176.0K
  • OTLY 158.4K
  • Earning Date
  • PVLA 08-15-2025
  • OTLY 07-23-2025
  • Dividend Yield
  • PVLA N/A
  • OTLY N/A
  • EPS Growth
  • PVLA N/A
  • OTLY N/A
  • EPS
  • PVLA N/A
  • OTLY N/A
  • Revenue
  • PVLA N/A
  • OTLY $828,200,000.00
  • Revenue This Year
  • PVLA N/A
  • OTLY $4.68
  • Revenue Next Year
  • PVLA N/A
  • OTLY $4.78
  • P/E Ratio
  • PVLA N/A
  • OTLY N/A
  • Revenue Growth
  • PVLA N/A
  • OTLY 4.43
  • 52 Week Low
  • PVLA $11.17
  • OTLY $6.00
  • 52 Week High
  • PVLA $40.50
  • OTLY $20.80
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • OTLY 65.35
  • Support Level
  • PVLA N/A
  • OTLY $14.30
  • Resistance Level
  • PVLA N/A
  • OTLY $15.50
  • Average True Range (ATR)
  • PVLA 0.00
  • OTLY 0.77
  • MACD
  • PVLA 0.00
  • OTLY -0.02
  • Stochastic Oscillator
  • PVLA 0.00
  • OTLY 83.15

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

Share on Social Networks: